NHIA Receives Honor from NewYorkBIO
October 3, 2022 – At its Annual Meeting on September 28, The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
The COVID Heroes of New York awards showcase members of NewYorkBIO who were at “ground zero” when the pandemic swept the United States and pulled together to keep Americans and America’s health care workforce safe. The award was presented to NHIA on behalf of its member pharmacies that participated in a pilot program to administer the life-saving monoclonal antibodies to nursing home residents and staff at the beginning of the pandemic. Infusion pharmacies track and report patient outcomes, which helped the association secure Medicare reimbursement for home administration of monoclonals to patients for whom clinic-based infusions are not feasible or clinically appropriate.
“NewYorkBIO was pleased to honor a number of individuals as COVID Heroes. I am in awe of the work that Connie and her colleagues at NHIA did to ensure that patients had access to the COVID treatments they needed in a safe environment like home, including nursing homes,” said Jennifer Hawks Bland, CEO NewYorkBIO.
The National Home Infusion Association (NHIA) is pleased to hold its second annual one-day Payor Summit. The event, designed to bring together representatives from commercial health insurance plans with home and specialty infusion leaders, will take place August 23, 2023 in Dallas, TX.
NHIA has released a draft practice standard that describes situations that may require the use of electronic mechanical pumps to minimize adverse reactions and promote adherence to infusion therapies administered in the home.
The National Home Infusion Association (NHIA) applaudes the introduction of bipartisan legislation in the U.S. Senate that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
